(Q42845480)

8 November 2017

title

Transplantation: can sirolimus prevent skin cancer in transplant recipients? (English)

1 reference

8 November 2017

1 reference

1 reference

1

Edward K Geissler

1 reference

8 November 2017

Hans J Schlitt

2

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

Nature Reviews Nephrology

8 November 2017

published in

1 reference

8 November 2017

volume

6

1 reference

8 November 2017

issue

11

1 reference

8 November 2017

page(s)

639-641

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2010.130

8 November 2017

exact match

0 references

cites work

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.130

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.130

Skin cancer in organ transplant recipients--where do we stand today?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.130

Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.130

mTOR, cancer and transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.130

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.130

Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.130

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.130

Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.130

mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field?

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20981120

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEPH.2010.130

1 reference

8 November 2017

1 reference